Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia
This phase II trial tests how well venetoclax works in treating patients with hairy cell leukemia that has come back after a period of improvement (relapsed). …
Recurrent Hairy Cell LeukemiaRecurrent Hairy Cell Leukemia Variant
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT06311227
Phase 1
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Background: CAR (Chimeric Antigen Receptor) T cell therapy is a type of cancer treatment in which a person s T cells (a type of immune cell) are changed in a …
Hairy Cell LeukemiaHairy Cell Leukemia Variant
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT04815356